Recruiting studies: Hiv Preexposure Prophylaxis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · 30 location(s) · Merck Sharp & Dohme LLC · NCT07071623 The SwissPrEPared Study
Phase N/A · 41 location(s) · University of Zurich · NCT03893188 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297 The Collaborative Care PrTNER Study
NA · 2 location(s) · Children's Hospital of Philadelphia · NCT06585631 California MEPS Hub
NA · 3 location(s) · University of California, Los Angeles · NCT07433985

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.